9 results
Real-world savings in medication-related costs up to 5 years with the use of the second-generation trabecular implant (iStent inject®) in mild open-angle glaucoma
137
Real-world evidence of the costs avoided over one year with the use of selective laser trabeculoplasty as a substitute therapy for eye drops
280
A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma
803
Estimating the cost of training an ophthalmologist in Brazil
2,338
Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis
725
Financial impact on glaucoma surgical treatment
210
Cost analysis for ophthalmic clinics services
313
Phacoemulsification versus extracapsular extraction on public health care system: cost analysis to the hospital, to the government and to the society
118
1 2